Skip to content
PeptideAgent

Telehealth providers in North Dakota

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in North Dakota. What North Dakota requires of telehealth prescribers and pharmacies, plus verified listings.

North Dakota at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving North Dakota

No verified telehealth providers serving North Dakota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in North Dakota

NDCC 43-17-44 requires a physician or physician assistant practicing telemedicine to establish a bona fide relationship with the patient before diagnosis or treatment, verify the patient's identity, disclose their own identity and licensure, and meet the same standard of care and ethics as in-person practice. The Board of Medicine's telemedicine rules in NDAC chapter 50-02-15 implement the statute, and prescribing controlled substances over the internet requires a valid prescription. The prescriber must hold a North Dakota license. Neither source confirmed for this draft addresses whether a questionnaire-only asynchronous encounter can create the bona fide relationship, so asynchronous prescribing is left unconfirmed. None of the peptides in this database are controlled substances. [2] [3]

Compounded GLP-1 access in North Dakota

Because North Dakota requires a full pharmacy permit for every out-of-state shipper, fewer national telehealth pharmacies serve the state, and patients should confirm the pharmacy's North Dakota permit before ordering. [4] [9]

Research use only sellers in North Dakota

The North Dakota Food, Drug, and Cosmetic Act (NDCC chapter 19-02.1) prohibits selling adulterated or misbranded drugs, and NDCC chapter 43-15 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners. [6] [7] [10]

How to check a telehealth provider in North Dakota

  1. Confirm the prescriber is licensed or registered to treat patients located in North Dakota; the telehealth rules above explain what North Dakota requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the North Dakota State Board of Pharmacy license lookup. [1] [4] [5] [6] [8]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in North Dakota. [6] [7] [10]

Common questions in North Dakota

Can an out-of-state pharmacy ship compounded peptides to me in North Dakota?

Only if it holds a North Dakota pharmacy permit issued by the State Board of Pharmacy. North Dakota requires every pharmacy that ships prescription drugs into the state to hold a permit and follow North Dakota rules for that dispensing. [1] [4]

All peptide legal questions for North Dakota

Sources

  1. [1]North Dakota State Board of Pharmacy
  2. [2]NDCC 43-17-44, Telemedicine (in chapter 43-17, Physicians and physician assistants)
  3. [3]NDAC chapter 50-02-15, Telemedicine (North Dakota Board of Medicine)
  4. [4]NDAC chapter 61-08-01, Requirements for out-of-state pharmacies
  5. [5]NDAC chapter 61-02-01, Pharmacy permits (section 61-02-01-03, pharmaceutical compounding standards)
  6. [6]NDCC chapter 43-15, Pharmacy (including 43-15-35, pharmacist ownership)
  7. [7]NDCC chapter 19-02.1, Food, Drug, and Cosmetic Act
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts